Evidence map›Paper›PMID 40616605›Full record

ArticleUrolithiasis2025

Prediction of postoperative SIRS risk factors in MetS patients undergoing PCNL.

Song Wei, Shu-Hao Li, Bo-Ran Lv, Bai-Yu Liu, Hua Wang, Cheng Hu

Abstract read
In one paragraph

Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Song WeiDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong, People's Republic of China.
Shu-Hao LiDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong, People's Republic of China.
Bo-Ran LvDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong, People's Republic of China.
Bai-Yu LiuDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong, People's Republic of China.
Hua WangDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong, People's Republic of China. wangh585@mail.sysu.edu.cn.
Cheng HuDepartment of Urology, The Third Affiliated Hospital, Sun Yat-sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong, People's Republic of China. hucheng2@mail.sysu.edu.cn.

Funding

Natural Science Foundation of Guangdong Province NO. 2025A1515012973
6 · The paper itself

Abstract

This study aimed to identify preoperative risk factors for systemic inflammatory response syndrome (SIRS) in patients with metabolic syndrome (MetS) undergoing percutaneous nephrolithotomy (PCNL) and to develop a predictive nomogram for individualized risk stratification. A retrospective analysis was conducted on 245 MetS patients who underwent PCNL between January 2021 and December 2024, among whom 27.8% developed postoperative SIRS. Patients were randomly assigned to training and validation cohorts in a 7:3 ratio. Least absolute shrinkage and selection operator (LASSO) regression was initially applied to select candidate predictors, followed by univariate and multivariate logistic regression analyses to identify independent risk factors. A nomogram was subsequently constructed based on the significant variables and evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Multivariate analysis identified five independent predictors of postoperative SIRS: higher standard deviation of stone density, reduced renal parenchymal thickness, increased lateral and posterior perirenal fat thicknesses, and the presence of staghorn calculi (P < 0.05). The nomogram demonstrated good discriminative ability, with an area under the ROC curve (AUC) of 0.888 (95% CI: 0.834-0.942) in the training cohort and 0.882 (95% CI: 0.802-0.962) in the validation cohort. The calibration curve and the Hosmer-Lemeshow test (P = 0.1485) indicated good model calibration and fit. DCA further confirmed the clinical utility of the model. This nomogram offers a reliable preoperative tool for SIRS risk stratification in MetS patients undergoing PCNL, aiding early intervention and personalized perioperative management.

Indexed as

Kidney CalculiMetabolic SyndromeNephrolithotomy, PercutaneousPostoperative ComplicationsSystemic Inflammatory Response SyndromeAdultAgedFemaleHumansMaleMiddle AgedNomogramsRetrospective StudiesRisk AssessmentRisk FactorsROC CurveKidney stonesMetabolic syndromeNomogramPercutaneous nephrolithotomySystemic inflammatory response syndrome

Identifiers

PMID40616605
PMCPMC12228654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.